/**
 * Cartalax — research enrichment. NO PubMed-indexed primary source was
 * located during this review.
 *
 * Unlike Adamax (which appears to have no real research-program lineage
 * at all), Cartalax is plausibly a genuine member of Khavinson's
 * short-chain peptide bioregulator family (St. Petersburg Institute of
 * Bioregulation and Gerontology) — the same research program that
 * produced Epithalon (verified real human/animal literature exists,
 * see epithalon-compound.mjs), Thymalin, and other AEDG/AEDL-family
 * tetrapeptides. However, a direct PubMed search for "Cartalax" in
 * NCBI E-utilities returned no on-topic results (the search matched
 * unrelated "alanyl-glutamyl-aspartic acid" records, not a specific
 * Cartalax study), and the specific "2014 Bulletin of Experimental
 * Biology and Medicine rat cartilage study" widely cited by vendor
 * pages could not be independently located or verified via PubMed in
 * this review. This is flagged for follow-up (a Russian-language
 * literature search, or direct contact with the Khavinson institute's
 * publication list, may locate it) rather than cited on the strength of
 * vendor-page claims alone.
 *
 * @type {import('../schema.mjs').CompoundEnrichment}
 */
import { policyReconciliation } from '../legacy-boilerplate.mjs';

export default {
  slug: 'cartalax',
  sources: [],
  claims: [
    {
      contentSection: 'safety',
      statement:
        'As of this review, no PubMed-indexed peer-reviewed study specifically on Cartalax was located, despite Cartalax plausibly belonging to a real, independently-verified family of short-chain peptide bioregulators (the Khavinson-institute AEDG/AEDL tetrapeptide series, which includes Epithalon — see epithalon-compound.mjs). The specific rat-cartilage study widely referenced by commercial vendor pages could not be independently confirmed via PubMed/NCBI E-utilities in this review.',
      interpretationStatus: 'insufficient',
      sources: [],
    },
  ],
  regulatoryRecords: [],
  legacyReconciliations: [
    {
      legacyClaimId: 'c9e2674d-1a34-4387-a958-bc2888a309e1',
      legacyStatementExcerpt: 'Cartalax is a peptide investigated in laboratory studies involving cartilage and connective tissue biology',
      disposition: 'unsupported',
      rationale: 'No independently verifiable PubMed-indexed primary source for Cartalax was located during this review — see the compound-level note above. Not established as false, only as currently unverified by an authoritative source in this pipeline.',
      evidenceQuality: 'not_assessed',
      interpretationStatus: 'insufficient',
      sources: [],
    },
    {
      legacyClaimId: '00dfe217-b05b-444b-b8bf-68859124a1f6',
      legacyStatementExcerpt: 'Current research focuses on joint physiology, tissue maintenance, regenerative biology, and age-related changes in connective tissue',
      disposition: 'unsupported',
      rationale: 'Same finding — no independently verifiable primary source located.',
      evidenceQuality: 'not_assessed',
      interpretationStatus: 'insufficient',
      sources: [],
    },
    {
      legacyClaimId: '7e12ffca-45aa-4b47-a267-80cd4278d874',
      legacyStatementExcerpt: 'Scientists investigate Cartalax for its influence on gene expression and peptide signaling associated with cartilage maintenance',
      disposition: 'unsupported',
      rationale: 'Same finding — the specific gene-expression mechanism claimed by vendor pages (COL2A1/aggrecan upregulation) could not be traced to a verifiable primary source in this review.',
      evidenceQuality: 'not_assessed',
      interpretationStatus: 'insufficient',
      sources: [],
    },
    {
      legacyClaimId: '824a23e3-1a2d-4e2e-a31c-5ba0ee097e53',
      legacyStatementExcerpt: 'Q: What is Cartalax researched for? A: Published laboratory research primarily investigates cartilage biology',
      disposition: 'unsupported',
      rationale: 'Same finding — no independently verifiable "published" research located for this specific compound.',
      evidenceQuality: 'not_assessed',
      interpretationStatus: 'insufficient',
      sources: [],
    },
    {
      legacyClaimId: 'aacf7fc6-a3fd-4319-bc18-e3d2ce313324',
      legacyStatementExcerpt: 'Q: Is Cartalax intended for human use? A: No. Cloud Peptides sells products strictly for laboratory research purposes only',
      disposition: 'supported',
      rationale: 'Site-policy statement, not a scientific claim about the compound\'s properties; true by direct inspection of site policy.',
      evidenceQuality: 'not_assessed',
      interpretationStatus: 'established',
      sources: [],
    },
    policyReconciliation('07158aa9-c1f4-44e4-8c07-245f2e5f7c09', 'Q: Does Cloud Peptides provide dosage information? A: No.'),
    policyReconciliation('c80d226b-4e20-46b8-894e-fde57c3033a5', 'This page summarizes publicly available scientific literature for educational purposes only.'),
    policyReconciliation('f69657eb-e898-4cc6-9455-3cea172077d9', 'Cloud Peptides does not provide medical advice, treatment recommendations, or dosage information.'),
    policyReconciliation('cc20b884-aea9-4802-b4d9-d9f648c09db7', 'All products are intended strictly for laboratory research purposes only'),
  ],
};
